Camp4 Therapeutics (CAMP) Income from Continuing Operations (2023 - 2026)

Camp4 Therapeutics has reported Income from Continuing Operations for 4 years, with the latest figure at 12217000.0 in Q1 2026.

• Quarterly Income from Continuing Operations rose 10.49% year-over-year to 12217000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 56121000.0 (up 8.65% YoY) and the FY2025 annual result came in at 126521000.0, down 8.44% from the prior year.
• Income from Continuing Operations eased to 12217000.0 in Q1 2026 per CAMP's latest filing, from 9671000.0 in the prior quarter.
• Over five years, Income from Continuing Operations peaked at 9671000.0 in Q4 2025 and troughed at 23775000.0 in Q3 2024.
• A 4-year average of 14230545.45 and a median of 13081000.0 in 2024 frame the typical range for Income from Continuing Operations.
• The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations slumped 91.67% in 2024, then surged 40.68% in 2025.
• Over 4 years, Income from Continuing Operations stood at 12990000.0 in 2023, then climbed by 15.83% to 10934000.0 in 2024, then rose by 11.55% to 9671000.0 in 2025, then fell by 26.33% to 12217000.0 in 2026.
• According to Business Quant data, Income from Continuing Operations over the past three periods registered 12217000.0, 9671000.0, and 14104000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.